Singapore General Hospital (SGH) is developing an artificial intelligence solution called 'Augmented Intelligent Infectious Diseases' (AI2D), aimed at determining the necessity of prescribing antibiotics, reducing antibiotic usage, and identifying the most appropriate antibiotic for each patient. The project is in collaboration with DXC Technology and currently covers pneumonia cases. The AI2D model is built on de-identified clinical data of approximately 8,000 SGH patients from 2019 to 2020, including X-rays, clinical symptoms, vital signs, and infection responses.
